Guarantor Subsidiaries (Schedule of Condensed Financial Statements) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Summary Consolidating Statements of Income [Abstract]
Revenue, Net	$ 1,529,945	$ 1,501,348	$ 1,536,027	$ 1,593,068	$ 1,557,085	$ 1,544,360	$ 1,555,906	$ 1,525,571	$ 6,160,388	$ 6,182,922	$ 6,030,670
Cost of Goods and Services Sold	1,153,281	1,130,053	1,168,681	1,224,968	1,197,401	1,198,299	1,219,513	1,190,612	4,676,983	4,805,825	4,694,440
Gross Profit	376,664	371,295	367,346	368,100	359,684	346,061	336,393	334,959	1,483,405	1,377,097	1,336,230
Selling, General and Administrative Expense	214,090	203,550	201,878	200,124	199,902	191,293	192,474	190,166	819,642	773,835	747,608
Provision for Doubtful Accounts	26,851	24,047	24,078	24,431	25,410	24,255	24,357	24,530	99,407	98,552	136,630
Litigation And Other Professional Fees	11,148	4,931	26,093	7,203	23,103	6,742	19,816	6,013	49,375	55,674	113,709
Other Cost and Expense, Operating	2,046	5,036	49,209	11,512	5,154	6,718	2,332	1,889	67,803	16,093	149,129
Operating Income (Loss)	122,529	133,731	66,088	124,830	106,115	117,053	97,414	112,361	447,178	432,943	189,154
Interest Income (Expense), Net	29,659	39,036	35,574	30,834	36,080	55,926	33,730	34,382	(135,103)	(160,118)	(155,646)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest	92,870	94,695	30,514	93,996	70,035	61,127	63,684	77,979	312,075	272,825	33,508
Income Tax Expense (Benefit)	33,852	33,270	11,822	38,257	31,723	23,343	27,403	28,824	117,201	111,293	19,044
Income (loss) from continuing operations	59,018	61,425	18,692	55,739	38,312	37,784	36,281	49,155	194,874	161,532	14,464
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	0	0	0		(7,129)	(9,900)	(37,728)	(19,851)	0	(74,608)	(120,573)
Income (Loss) from Equity Method Investments									0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	59,018	61,425	18,692	55,739	31,183	27,884	(1,447)	29,304	194,874	86,924	(106,109)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									194,744	80,952	(75,555)
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	454,213				580,262				454,213	580,262	494,484	275,707
Restricted Cash and Investments, Current	1,066				2,336				1,066	2,336
Accounts Receivable, Net, Current	857,052				931,314				857,052	931,314
Inventory, Net	385,698				419,378				385,698	419,378
Deferred Tax Assets, Net of Valuation Allowance, Current	136,186				153,444				136,186	153,444
Other Assets, Current	254,644				210,637				254,644	210,637
Assets, Current	2,088,859				2,297,371				2,088,859	2,297,371
Property, Plant and Equipment, Net	282,660				225,257				282,660	225,257
Goodwill	4,256,959				4,250,579				4,256,959	4,250,579	4,182,928
Intangible Assets, Net (Excluding Goodwill)	196,873				235,270				196,873	235,270
Other Assets, Noncurrent	163,913				184,633				163,913	184,633
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	0				0				0	0
Assets	6,989,264				7,193,110				6,989,264	7,193,110
Liabilities, Current	482,014				540,067				482,014	540,067
Long-term Debt, Excluding Current Maturities	2,030,030				1,968,274				2,030,030	1,968,274
Deferred Tax Liabilities, Net, Noncurrent	914,660				838,857				914,660	838,857
Other Liabilities, Noncurrent	56,848				50,476				56,848	50,476
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	3,505,712				3,795,436				3,505,712	3,795,436	3,818,761	3,878,810
Liabilities and Equity	6,989,264				7,193,110				6,989,264	7,193,110
Condensed Consolidating Statements of Cash Flows [Abstract]
Net Cash Provided by (Used in) Operating Activities									544,484	550,022	368,615
Payments to Acquire Businesses, Net of Cash Acquired									(34,873)	(101,933)	(111,812)
Divestiture of business, net									19,207	13,099	0
Payments to Acquire Property, Plant, and Equipment									(99,920)	(62,806)	(23,517)
Payments to Acquire Marketable Securities									(25,018)	0	0
Increase (decrease) in cash transfers to trusts for employee benefit costs									1,326	(275)	11,082
Consolidated Other Proceeds from (expenditures in) Investing Activities									(56)	(3,496)	(1,805)
Net Cash Provided by (Used in) Investing Activities									(139,334)	(155,411)	(126,052)
(Payments of) Proceeds from Revolving Credit Facility and Term Loans									(24,688)	(5,625)	(125,000)
Proceeds from long term borrowings and obligations									425,000	600,000	975,000
Repayments of Other Long-term Debt									(453,573)	(777,609)	(726,533)
Payments of Debt Issuance Costs									(7,566)	(13,780)	(33,249)
Proceeds from (Repayments of) Bank Overdrafts									(14,927)	11,674	18,221
Payments for Repurchase of Common Stock									(388,968)	(140,127)	(100,942)
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options									24,951	30,712	(13,989)
Payments of Ordinary Dividends, Common Stock									(45,214)	(17,217)	(12,839)
Consolidated Other Proceeds from (used in) Financing Activities									1,912	3,140	(5,289)
Option indexed to issuers equity cash paid									(48,126)	0	0
Net Cash Provided by (Used in) Financing Activities									(531,199)	(308,832)	(24,620)
Cash and Cash Equivalents, Period Increase (Decrease)									(126,049)	85,779	217,943
Cash and Cash Equivalents Period Increase (Decrease) from Continuing Operations									(126,049)	85,778	218,777
Net Cash Provided by (Used in) Discontinued Operations									0	1	(834)
Parent Company [Member]
Summary Consolidating Statements of Income [Abstract]
Revenue, Net									0	0	0
Cost of Goods Sold									0	0	0
Gross Profit									0	0	0
Selling, General and Administrative Expense									4,816	15,579	9,569
Provision for Doubtful Accounts									0	0	0
Litigation And Other Professional Fees									0	0	0
Other Cost and Expense, Operating									35,092	0	0
Operating Income (Loss)									(39,908)	(15,579)	(9,569)
Interest Income (Expense), Net									(133,368)	(158,621)	(162,925)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									(173,276)	(174,200)	(172,494)
Income Tax Expense (Benefit)									(66,763)	(66,753)	(64,478)
Income (loss) from continuing operations									(106,513)	(107,447)	(108,016)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest									0	0	0
Income (Loss) from Equity Method Investments									301,387	194,371	1,907
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest									194,874	86,924	(106,109)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									194,744	80,952	(75,555)
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	383,674				460,253				383,674	460,253	460,778	230,866
Restricted Cash and Investments, Current	0				0				0	0
Accounts Receivable, Net, Current	0				0				0	0
Inventory, Net	0				0				0	0
Deferred Tax Assets, Net of Valuation Allowance, Current	0				0				0	0
Other Assets, Current	1,765				3,865				1,765	3,865
Assets, Current	385,439				464,118				385,439	464,118
Property, Plant and Equipment, Net	0				0				0	0
Goodwill	0				0				0	0
Intangible Assets, Net (Excluding Goodwill)	0				0				0	0
Other Assets, Noncurrent	75,336				77,485				75,336	77,485
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	5,453,702				5,593,155				5,453,702	5,593,155
Assets	5,914,477				6,134,758				5,914,477	6,134,758
Liabilities, Current	60,454				59,596				60,454	59,596
Long-term Debt, Excluding Current Maturities	2,012,807				1,957,167				2,012,807	1,957,167
Deferred Tax Liabilities, Net, Noncurrent	335,504				322,559				335,504	322,559
Other Liabilities, Noncurrent	0				0				0	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	3,505,712				3,795,436				3,505,712	3,795,436
Liabilities and Equity	5,914,477				6,134,758				5,914,477	6,134,758
Condensed Consolidating Statements of Cash Flows [Abstract]
Net Cash Provided by (Used in) Operating Activities									(88,461)	(118,642)	(86,774)
Payments to Acquire Businesses, Net of Cash Acquired									0	0	0
Divestiture of business, net									0	0	0
Payments to Acquire Property, Plant, and Equipment									0	0	0
Payments to Acquire Marketable Securities									(25,514)
Increase (decrease) in cash transfers to trusts for employee benefit costs									0	0	0
Consolidated Other Proceeds from (expenditures in) Investing Activities									0	0	0
Net Cash Provided by (Used in) Investing Activities									(25,514)	0	0
(Payments of) Proceeds from Revolving Credit Facility and Term Loans									(24,688)	(5,625)	(125,000)
Proceeds from long term borrowings and obligations									425,000	600,000	975,000
Repayments of Other Long-term Debt									(453,573)	(777,609)	(726,533)
Payments of Debt Issuance Costs									(7,566)	(13,780)	(33,249)
Proceeds from (Repayments of) Bank Overdrafts									(12)	5,921	9,744
Payments for Repurchase of Common Stock									(388,968)	(140,127)	(100,942)
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options									24,951	30,712	(13,989)
Payments of Ordinary Dividends, Common Stock									(45,214)	(17,217)	(12,839)
Consolidated Other Proceeds from (used in) Financing Activities									555,592	435,842	344,494
Option indexed to issuers equity cash paid									(48,126)
Net Cash Provided by (Used in) Financing Activities									37,396	118,117	316,686
Cash and Cash Equivalents, Period Increase (Decrease)									(76,579)	(525)	229,912
Cash and Cash Equivalents Period Increase (Decrease) from Continuing Operations										(525)	229,912
Net Cash Provided by (Used in) Discontinued Operations										0	0
Guarantor Subsidiaries [Member] | Senior Notes Payable [Member]
Summary Consolidating Statements of Income [Abstract]
Revenue, Net									6,023,153	6,057,114	5,891,219
Cost of Goods Sold									4,589,932	4,720,920	4,590,118
Gross Profit									1,433,221	1,336,194	1,301,101
Selling, General and Administrative Expense									793,205	746,579	722,789
Provision for Doubtful Accounts									97,862	96,623	134,391
Litigation And Other Professional Fees									49,375	55,674	113,709
Other Cost and Expense, Operating									36,723	16,093	149,129
Operating Income (Loss)									456,056	421,225	181,083
Interest Income (Expense), Net									(1,089)	(1,491)	7,279
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									454,967	419,734	188,362
Income Tax Expense (Benefit)									173,729	167,588	82,225
Income (loss) from continuing operations									281,238	252,146	106,137
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest										(71,425)	(85,684)
Income (Loss) from Equity Method Investments									0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest									281,238	180,721	20,453
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									281,238	180,721	20,453
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	58,312				101,786				58,312	101,786	17,598	32,202
Restricted Cash and Investments, Current	1,066				2,336				1,066	2,336
Accounts Receivable, Net, Current	849,753				920,829				849,753	920,829
Inventory, Net	379,448				412,081				379,448	412,081
Deferred Tax Assets, Net of Valuation Allowance, Current	137,736				156,139				137,736	156,139
Other Assets, Current	248,833				193,079				248,833	193,079
Assets, Current	1,675,148				1,786,250				1,675,148	1,786,250
Property, Plant and Equipment, Net	276,056				220,066				276,056	220,066
Goodwill	4,219,900				4,171,328				4,219,900	4,171,328
Intangible Assets, Net (Excluding Goodwill)	193,852				229,051				193,852	229,051
Other Assets, Noncurrent	93,508				100,725				93,508	100,725
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	0				0				0	0
Assets	6,458,464				6,507,420				6,458,464	6,507,420
Liabilities, Current	587,025				569,623				587,025	569,623
Long-term Debt, Excluding Current Maturities	17,223				11,107				17,223	11,107
Deferred Tax Liabilities, Net, Noncurrent	559,405				500,242				559,405	500,242
Other Liabilities, Noncurrent	68,161				50,476				68,161	50,476
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	5,226,650				5,375,972				5,226,650	5,375,972
Liabilities and Equity	6,458,464				6,507,420				6,458,464	6,507,420
Condensed Consolidating Statements of Cash Flows [Abstract]
Net Cash Provided by (Used in) Operating Activities									636,402	665,702	443,924
Payments to Acquire Businesses, Net of Cash Acquired									(34,873)	(101,933)	(111,812)
Divestiture of business, net									19,207	13,099	0
Payments to Acquire Property, Plant, and Equipment									(97,579)	(60,396)	(22,496)
Payments to Acquire Marketable Securities									0
Increase (decrease) in cash transfers to trusts for employee benefit costs									1,326	(275)	11,082
Consolidated Other Proceeds from (expenditures in) Investing Activities									(56)	(3,486)	(1,791)
Net Cash Provided by (Used in) Investing Activities									(111,975)	(152,991)	(125,017)
(Payments of) Proceeds from Revolving Credit Facility and Term Loans									0	0	0
Proceeds from long term borrowings and obligations									0	0	0
Repayments of Other Long-term Debt									0	0	0
Payments of Debt Issuance Costs									0	0
Proceeds from (Repayments of) Bank Overdrafts									(14,915)	5,753	8,477
Payments for Repurchase of Common Stock									0	0	0
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options									0	0	0
Payments of Ordinary Dividends, Common Stock									0	0	0
Consolidated Other Proceeds from (used in) Financing Activities									(552,986)	(434,276)	(342,826)
Option indexed to issuers equity cash paid									0
Net Cash Provided by (Used in) Financing Activities									(567,901)	(428,523)	(334,349)
Cash and Cash Equivalents, Period Increase (Decrease)									(43,474)	84,188	(15,442)
Cash and Cash Equivalents Period Increase (Decrease) from Continuing Operations										84,188	(14,604)
Net Cash Provided by (Used in) Discontinued Operations										0	838
Guarantor Subsidiaries [Member] | Convertible SeniorDebentures [Member]
Summary Consolidating Statements of Income [Abstract]
Revenue, Net									0	0	0
Cost of Goods Sold									0	0	0
Gross Profit									0	0	0
Selling, General and Administrative Expense									1,438	1,467	1,403
Provision for Doubtful Accounts									0	0	0
Litigation And Other Professional Fees									0	0	0
Other Cost and Expense, Operating									0	0	0
Operating Income (Loss)									(1,438)	(1,467)	(1,403)
Interest Income (Expense), Net									0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									(1,438)	(1,467)	(1,403)
Income Tax Expense (Benefit)									(557)	(562)	(524)
Income (loss) from continuing operations									(881)	(905)	(879)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest									0	0	0
Income (Loss) from Equity Method Investments									0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest									(881)	(905)	(879)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									(881)	(905)	(879)
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	0				0				0	0	0	0
Restricted Cash and Investments, Current	0				0				0	0
Accounts Receivable, Net, Current	204				177				204	177
Inventory, Net	0				0				0	0
Deferred Tax Assets, Net of Valuation Allowance, Current	0				0				0	0
Other Assets, Current	0				0				0	0
Assets, Current	204				177				204	177
Property, Plant and Equipment, Net	22				17				22	17
Goodwill	0				19				0	19
Intangible Assets, Net (Excluding Goodwill)	0				0				0	0
Other Assets, Noncurrent	19				0				19	0
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	0				0				0	0
Assets	245				213				245	213
Liabilities, Current	54				82				54	82
Long-term Debt, Excluding Current Maturities	0				0				0	0
Deferred Tax Liabilities, Net, Noncurrent	0				0				0	0
Other Liabilities, Noncurrent	0				0				0	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	191				131				191	131
Liabilities and Equity	245				213				245	213
Condensed Consolidating Statements of Cash Flows [Abstract]
Net Cash Provided by (Used in) Operating Activities									0	0	0
Payments to Acquire Businesses, Net of Cash Acquired									0	0	0
Divestiture of business, net									0	0	0
Payments to Acquire Property, Plant, and Equipment									0	0	0
Payments to Acquire Marketable Securities									0
Increase (decrease) in cash transfers to trusts for employee benefit costs									0	0	0
Consolidated Other Proceeds from (expenditures in) Investing Activities									0	0	0
Net Cash Provided by (Used in) Investing Activities									0	0	0
(Payments of) Proceeds from Revolving Credit Facility and Term Loans									0	0	0
Proceeds from long term borrowings and obligations									0	0	0
Repayments of Other Long-term Debt									0	0	0
Payments of Debt Issuance Costs									0	0
Proceeds from (Repayments of) Bank Overdrafts									0	0	0
Payments for Repurchase of Common Stock									0	0	0
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options									0	0	0
Payments of Ordinary Dividends, Common Stock									0	0	0
Consolidated Other Proceeds from (used in) Financing Activities									0		0
Option indexed to issuers equity cash paid									0
Net Cash Provided by (Used in) Financing Activities									0	0	0
Cash and Cash Equivalents, Period Increase (Decrease)									0	0	0
Cash and Cash Equivalents Period Increase (Decrease) from Continuing Operations										0	0
Net Cash Provided by (Used in) Discontinued Operations										0	0
Non-Guarantor Subsidiaries [Member] | Senior Notes Payable [Member]
Summary Consolidating Statements of Income [Abstract]
Revenue, Net									137,235	125,808	139,451
Cost of Goods Sold									87,051	84,905	104,322
Gross Profit									50,184	40,903	35,129
Selling, General and Administrative Expense									21,621	11,677	15,250
Provision for Doubtful Accounts									1,545	1,929	2,239
Litigation And Other Professional Fees									0	0	0
Other Cost and Expense, Operating									(4,012)	0	0
Operating Income (Loss)									31,030	27,297	17,640
Interest Income (Expense), Net									(646)	(6)	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									30,384	27,291	17,640
Income Tax Expense (Benefit)									10,235	10,458	1,297
Income (loss) from continuing operations									20,149	16,833	16,343
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest										(3,183)	(34,889)
Income (Loss) from Equity Method Investments									0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest									20,149	13,650	(18,546)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									21,533	8,959	(22,353)
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	12,227				18,223				12,227	18,223	16,108	12,639
Restricted Cash and Investments, Current	0				0				0	0
Accounts Receivable, Net, Current	197,370				119,614				197,370	119,614
Inventory, Net	6,250				7,297				6,250	7,297
Deferred Tax Assets, Net of Valuation Allowance, Current	0				0				0	0
Other Assets, Current	14,871				13,693				14,871	13,693
Assets, Current	230,718				158,827				230,718	158,827
Property, Plant and Equipment, Net	6,604				5,191				6,604	5,191
Goodwill	37,059				79,251				37,059	79,251
Intangible Assets, Net (Excluding Goodwill)	3,021				6,219				3,021	6,219
Other Assets, Noncurrent	11,382				6,423				11,382	6,423
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	0				0				0	0
Assets	288,784				255,911				288,784	255,911
Liabilities, Current	35,431				19,977				35,431	19,977
Long-term Debt, Excluding Current Maturities	5,000				0				5,000	0
Deferred Tax Liabilities, Net, Noncurrent	21,301				18,751				21,301	18,751
Other Liabilities, Noncurrent	0				0				0	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	227,052				217,183				227,052	217,183
Liabilities and Equity	288,784				255,911				288,784	255,911
Condensed Consolidating Statements of Cash Flows [Abstract]
Net Cash Provided by (Used in) Operating Activities									(3,457)	2,962	11,465
Payments to Acquire Businesses, Net of Cash Acquired									0	0	0
Divestiture of business, net									0	0	0
Payments to Acquire Property, Plant, and Equipment									(2,341)	(2,410)	(1,021)
Payments to Acquire Marketable Securities									496
Increase (decrease) in cash transfers to trusts for employee benefit costs									0	0	0
Consolidated Other Proceeds from (expenditures in) Investing Activities									0	(10)	(14)
Net Cash Provided by (Used in) Investing Activities									(1,845)	(2,420)	(1,035)
(Payments of) Proceeds from Revolving Credit Facility and Term Loans									0	0	0
Proceeds from long term borrowings and obligations									0	0	0
Repayments of Other Long-term Debt									0	0	0
Payments of Debt Issuance Costs									0	0
Proceeds from (Repayments of) Bank Overdrafts									0	0	0
Payments for Repurchase of Common Stock									0	0	0
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options									0	0	0
Payments of Ordinary Dividends, Common Stock									0	0	0
Consolidated Other Proceeds from (used in) Financing Activities									(694)	1,574	(6,957)
Option indexed to issuers equity cash paid									0
Net Cash Provided by (Used in) Financing Activities									(694)	1,574	(6,957)
Cash and Cash Equivalents, Period Increase (Decrease)									(5,996)	2,116	3,473
Cash and Cash Equivalents Period Increase (Decrease) from Continuing Operations										2,115	3,469
Net Cash Provided by (Used in) Discontinued Operations										(1)	(4)
Non-Guarantor Subsidiaries [Member] | Convertible SeniorDebentures [Member]
Summary Consolidating Statements of Income [Abstract]
Revenue, Net									6,160,388	6,182,922	6,030,670
Cost of Goods Sold									4,676,983	4,805,825	4,694,440
Gross Profit									1,483,405	1,377,097	1,336,230
Selling, General and Administrative Expense									813,388	756,789	736,636
Provision for Doubtful Accounts									99,407	98,552	136,630
Litigation And Other Professional Fees									49,375	55,674	113,709
Other Cost and Expense, Operating									32,711	16,093	149,129
Operating Income (Loss)									488,524	449,989	200,126
Interest Income (Expense), Net									(1,735)	(1,497)	7,279
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									486,789	448,492	207,405
Income Tax Expense (Benefit)									184,521	178,608	84,046
Income (loss) from continuing operations									302,268	269,884	123,359
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest									0	(74,608)	(120,573)
Income (Loss) from Equity Method Investments									0	0	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest									302,268	195,276	2,786
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									303,652	190,585	(1,021)
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	70,539				120,009				70,539	120,009	33,706	44,841
Restricted Cash and Investments, Current	1,066				2,336				1,066	2,336
Accounts Receivable, Net, Current	857,052				931,314				857,052	931,314
Inventory, Net	385,698				419,378				385,698	419,378
Deferred Tax Assets, Net of Valuation Allowance, Current	137,736				153,989				137,736	153,989
Other Assets, Current	252,879				206,772				252,879	206,772
Assets, Current	1,704,970				1,833,798				1,704,970	1,833,798
Property, Plant and Equipment, Net	282,638				225,240				282,638	225,240
Goodwill	4,256,959				4,250,560				4,256,959	4,250,560
Intangible Assets, Net (Excluding Goodwill)	196,873				235,270				196,873	235,270
Other Assets, Noncurrent	88,558				107,148				88,558	107,148
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	0				0				0	0
Assets	6,529,998				6,652,016				6,529,998	6,652,016
Liabilities, Current	421,710				480,566				421,710	480,566
Long-term Debt, Excluding Current Maturities	17,223				11,107				17,223	11,107
Deferred Tax Liabilities, Net, Noncurrent	580,706				516,843				580,706	516,843
Other Liabilities, Noncurrent	56,848				50,476				56,848	50,476
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	5,453,511				5,593,024				5,453,511	5,593,024
Liabilities and Equity	6,529,998				6,652,016				6,529,998	6,652,016
Condensed Consolidating Statements of Cash Flows [Abstract]
Net Cash Provided by (Used in) Operating Activities									632,945	668,664	455,389
Payments to Acquire Businesses, Net of Cash Acquired									(34,873)	(101,933)	(111,812)
Divestiture of business, net									19,207	13,099	0
Payments to Acquire Property, Plant, and Equipment									(99,920)	(62,806)	(23,517)
Payments to Acquire Marketable Securities									496
Increase (decrease) in cash transfers to trusts for employee benefit costs									1,326	(275)	11,082
Consolidated Other Proceeds from (expenditures in) Investing Activities									(56)	(3,496)	(1,805)
Net Cash Provided by (Used in) Investing Activities									(113,820)	(155,411)	(126,052)
(Payments of) Proceeds from Revolving Credit Facility and Term Loans									0	0	0
Proceeds from long term borrowings and obligations									0	0	0
Repayments of Other Long-term Debt									0	0	0
Payments of Debt Issuance Costs									0	0	0
Proceeds from (Repayments of) Bank Overdrafts									(14,915)	5,753	8,477
Payments for Repurchase of Common Stock									0	0	0
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options									0	0	0
Payments of Ordinary Dividends, Common Stock									0	0	0
Consolidated Other Proceeds from (used in) Financing Activities									(553,680)	(432,702)	(349,783)
Option indexed to issuers equity cash paid									0
Net Cash Provided by (Used in) Financing Activities									(568,595)	(426,949)	(341,306)
Cash and Cash Equivalents, Period Increase (Decrease)									(49,470)	86,304	(11,969)
Cash and Cash Equivalents Period Increase (Decrease) from Continuing Operations										86,303	(11,135)
Net Cash Provided by (Used in) Discontinued Operations										1	834
Consolidating, Eliminating Adjustments [Member] | Senior Notes Payable [Member]
Summary Consolidating Statements of Income [Abstract]
Revenue, Net									0	0	0
Cost of Goods Sold									0	0	0
Gross Profit									0	0	0
Selling, General and Administrative Expense									0	0	0
Provision for Doubtful Accounts									0	0	0
Litigation And Other Professional Fees									0	0	0
Other Cost and Expense, Operating									0	0	0
Operating Income (Loss)									0	0	0
Interest Income (Expense), Net									0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									0	0	0
Income Tax Expense (Benefit)									0	0	0
Income (loss) from continuing operations									0	0	0
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest										0	0
Income (Loss) from Equity Method Investments									(301,387)	(194,371)	(1,907)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest									(301,387)	(194,371)	(1,907)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									(302,771)	(189,680)	1,900
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	0				0				0	0
Restricted Cash and Investments, Current	0				0				0	0
Accounts Receivable, Net, Current	(190,071)				(109,129)				(190,071)	(109,129)
Inventory, Net	0				0				0	0
Deferred Tax Assets, Net of Valuation Allowance, Current	(1,550)				(2,695)				(1,550)	(2,695)
Other Assets, Current	(10,825)				0				(10,825)	0
Assets, Current	(202,446)				(111,824)				(202,446)	(111,824)
Property, Plant and Equipment, Net	0				0				0	0
Goodwill	0				0				0	0
Intangible Assets, Net (Excluding Goodwill)	0				0				0	0
Other Assets, Noncurrent	(16,313)				0				(16,313)	0
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	(5,453,702)				(5,593,155)				(5,453,702)	(5,593,155)
Assets	(5,672,461)				(5,704,979)				(5,672,461)	(5,704,979)
Liabilities, Current	(200,896)				(109,129)				(200,896)	(109,129)
Long-term Debt, Excluding Current Maturities	(5,000)				0				(5,000)	0
Deferred Tax Liabilities, Net, Noncurrent	(1,550)				(2,695)				(1,550)	(2,695)
Other Liabilities, Noncurrent	(11,313)				0				(11,313)	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(5,453,702)				(5,593,155)				(5,453,702)	(5,593,155)
Liabilities and Equity	(5,672,461)				(5,704,979)				(5,672,461)	(5,704,979)
Consolidating, Eliminating Adjustments [Member] | Convertible SeniorDebentures [Member]
Summary Consolidating Statements of Income [Abstract]
Revenue, Net									0	0	0
Cost of Goods Sold									0	0	0
Gross Profit									0	0	0
Selling, General and Administrative Expense									0	0	0
Provision for Doubtful Accounts									0	0	0
Litigation And Other Professional Fees									0	0	0
Other Cost and Expense, Operating									0	0	0
Operating Income (Loss)									0	0	0
Interest Income (Expense), Net									0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest									0	0	0
Income Tax Expense (Benefit)									0	0	0
Income (loss) from continuing operations									0	0	0
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest									0	0	0
Income (Loss) from Equity Method Investments									(301,387)	(194,371)	(1,907)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest									(301,387)	(194,371)	(1,907)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent									(302,771)	(189,680)	1,900
Condensed Consolidating Balance Sheets [Abstract]
Cash and Cash Equivalents, at Carrying Value	0				0				0	0
Restricted Cash and Investments, Current	0				0				0	0
Accounts Receivable, Net, Current	(204)				(177)				(204)	(177)
Inventory, Net	0				0				0	0
Deferred Tax Assets, Net of Valuation Allowance, Current	(1,550)				(545)				(1,550)	(545)
Other Assets, Current	0				0				0	0
Assets, Current	(1,754)				(722)				(1,754)	(722)
Property, Plant and Equipment, Net	0				0				0	0
Goodwill	0				0				0	0
Intangible Assets, Net (Excluding Goodwill)	0				0				0	0
Other Assets, Noncurrent	0				0				0	0
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	(5,453,702)				(5,593,155)				(5,453,702)	(5,593,155)
Assets	(5,455,456)				(5,593,877)				(5,455,456)	(5,593,877)
Liabilities, Current	(204)				(177)				(204)	(177)
Long-term Debt, Excluding Current Maturities	0				0				0	0
Deferred Tax Liabilities, Net, Noncurrent	(1,550)				(545)				(1,550)	(545)
Other Liabilities, Noncurrent	0				0				0	0
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(5,453,702)				(5,593,155)				(5,453,702)	(5,593,155)
Liabilities and Equity	$ (5,455,456)				$ (5,593,877)				$ (5,455,456)	$ (5,593,877)